designer491/iStock via Getty Images
Valneva (VALN) and the world’s largest vaccine maker, Serum Institute of India, announced on Wednesday that they have mutually agreed to discontinue their licensing agreement for the former’s chikungunya vaccine.
The companies identified the decision as a strategic move aimed